What medications cannot be taken with vitamin C?

The NIH's fact sheet for health professionals names two medication interactions for vitamin C, while consumer health pages routinely list a dozen.

That gap is not an oversight. Oral vitamin C has a hard ceiling: above 1 gram a day absorption falls below 50%, and plasma concentration plateaus near 220 micromoles per litre even at the highest oral doses modelled.

So what medications cannot be taken with vitamin C? Here is what the evidence supports, what it does not, and the one interaction that runs in the opposite direction from the warning you have read.

Table of Contents

• 1. The two medications the NIH actually names
• 2. Cancer treatment: why the answer is your oncologist
• 3. Statins with niacin: one trial, four antioxidants
• 4. Levothyroxine: the interaction that runs the other way
• 5. The warnings that did not survive testing
• 6. Named everywhere, absent from the NIH's list
• 7. The interaction nobody warns you about: your lab results
• 8. Bio Absorb Liposomal Vitamin C — fitting a supplement around a prescription
• Frequently Asked Questions
• Conclusion
• Research References

1. The two medications the NIH actually names

The NIH Office of Dietary Supplements last updated its vitamin C fact sheet for health professionals in July 2025. Under interactions with medications it gives two examples: cancer treatment, and statins taken together with niacin.

Two is a strikingly short list for a supplement taken by a large share of adults, and the reason is pharmacological rather than editorial. At intakes of 30 to 180 mg a day your body absorbs 70% to 90% of the vitamin C you swallow, but above 1 gram a day that figure drops below 50% and the surplus leaves in your urine. Plasma concentration then plateaus near 220 micromoles per litre even at the maximum tolerated oral dose of 3 grams every four hours. Our guide to how liposomal vitamin C works explains where that ceiling comes from.

One qualification matters. The NIH presents its two entries as examples rather than as a complete list, and it advises anyone taking medications regularly to discuss their vitamin C intake with their healthcare provider. A short list is not the same as an empty one.

2. Cancer treatment: why the answer is your oncologist

This is the interaction where the honest answer is that nobody knows. A 2008 paper in Cancer Research found that vitamin C reduced the cytotoxic effect of several antineoplastic drugs in laboratory conditions, which would mean the supplement works against the treatment.

The NIH names six agents of particular concern — cyclophosphamide, chlorambucil, carmustine, busulfan, thiotepa and doxorubicin — while also noting the opposing argument that antioxidants might protect normal tissues during treatment. Both positions rest largely on laboratory and animal work rather than on trials in patients.

That is why the guidance stops at a conversation rather than a rule. Anyone undergoing chemotherapy or radiation should speak to their oncologist before taking vitamin C, particularly at doses approaching the 2,000 mg a day tolerable upper intake level. This is not a decision to make from a blog post, including this one.

3. Statins with niacin: one trial, four antioxidants

The second NIH example traces to a single study. In the HDL-Atherosclerosis Treatment Study, published in the New England Journal of Medicine in 2001, 160 patients with coronary disease and low HDL cholesterol received simvastatin plus niacin, an antioxidant mixture, both, or neither.

Adding the antioxidants blunted the rise in protective HDL that the simvastatin-niacin combination normally produces. The complication is that vitamin C was one of four antioxidants given together in that arm, so its individual contribution was never measured.

The NIH's resulting guidance is that providers should monitor lipid levels, not that patients must avoid vitamin C. If you take a statin, this is worth raising at your next review rather than acting on alone. Our article on vitamin C interactions with medications and supplements covers the supplement side of the same question.

4. Levothyroxine: the interaction that runs the other way

Almost every consumer page listing vitamin C interactions includes levothyroxine, and almost every one frames it as a warning. The direction is wrong. A 2014 trial in the Journal of Clinical Endocrinology & Metabolism found that vitamin C improved the absorption of levothyroxine in patients who had both hypothyroidism and gastritis.

A 2025 proof-of-concept pilot in Frontiers in Endocrinology extended the question to patients requiring more than 1.6 micrograms per kilogram per day of levothyroxine, giving 1 gram of vitamin C daily against placebo. It detected a therapeutic signal, mainly in clinical symptoms, and the authors were careful to note that the earlier evidence covered only the gastritis subgroup.

The practical consequence is counterintuitive. Better absorption of a drug with a narrow therapeutic range is not automatically good news, because starting or stopping 1 gram of vitamin C a day could shift how much levothyroxine actually reaches you. Keep the routine consistent, and tell your prescriber before you change it so your thyroid levels can be checked.

5. The warnings that did not survive testing

Some entries on the standard list have been tested and did not hold up. The best documented is hormonal birth control. A small study in 1981 suggested that vitamin C raised ethinyl estradiol levels, and that finding propagated for decades — but a later trial in 37 women taking a combined pill found that 1 gram of vitamin C daily did not raise ethinyl estradiol at all.

Aluminium-containing antacids are the other recurring entry, on the theory that vitamin C increases how much aluminium you absorb. The animal evidence does not support that cleanly: a 1990 study in rabbits found that ascorbate did not raise aluminium in any tissue examined and reduced it in bone, while increasing excretion. The NIH does not include aluminium antacids among its two examples.

None of this means the combination is studied to exhaustion. It means the warning rests on thinner ground than the confidence with which it is repeated, and that people with reduced kidney function — who clear aluminium poorly — remain the group with a genuine reason for caution. Our article on what you should not mix with vitamin C covers the supplement and food side of this ground.

6. Named everywhere, absent from the NIH's list

Search this question and you will meet a longer roster: warfarin, the HIV medication indinavir, barbiturates, tetracycline, and nitrate medications for heart disease. None of these appears in the NIH's two-example interactions section, which runs to two subsections and no more.

That absence is informative but not conclusive. Several of these claims originate in small reports from the 1970s, 80s and 90s that were never replicated at scale, which is a different situation from having been tested and refuted. A claim can be weakly evidenced rather than wrong.

The practical approach is the same either way. If you take any prescription medication regularly, tell your pharmacist what supplements you take and at what dose, and ask them to check your specific combination. That is a two-minute conversation with someone who has your full medication list, which no article can match.

7. The interaction nobody warns you about: your lab results

The most reliably documented effect of vitamin C on medical care is not on a drug at all. It is on diagnostic tests, and it reaches people at everyday doses rather than megadoses.

A 1986 study in Clinical Chemistry tested four reagent strip systems in people taking 350 to 1,000 mg of vitamin C daily and found that these common doses frequently interfered with all of them. Vitamin C can turn guaiac-based stool blood tests and urine dipsticks falsely negative — results that look reassuring when they are not.

Continuous glucose monitors are affected too. FDA review documentation for one sensor notes that more than 500 mg a day of ascorbic acid can affect sensor readings, which matters if you are adjusting insulin from those numbers. Tell the clinic what you take before testing, rather than deciding yourself whether to pause it.

8. Bio Absorb Liposomal Vitamin C — fitting a supplement around a prescription

If you take medication regularly, the useful questions about a vitamin C supplement are mostly about what is in it and how predictable it is, rather than what the label promises.

Bio Absorb Nutraceuticals manufactures in Canada in a GMP-certified facility, and every batch is third-party tested and non-irradiated. That matters more than usual here: if you are discussing a combination with a pharmacist, you want a product whose contents are verified rather than assumed.

Bio Absorb's Liposomal Vitamin C is available in a liquid and a capsule format, both verified corn-free, gluten-free, nut-free and vegan. The liquid mixes with water or juice, which makes it straightforward to take at a set time away from other medication. The capsules need no refrigeration and travel well, which suits people whose routine moves around.

The corn-free point is the genuine differentiator rather than a marketing line. Nearly all commercial ascorbic acid is corn-derived, and most liposomal brands do not address it, which leaves people managing a corn sensitivity alongside a medication schedule with very little to choose from. Both formats share the same formulation and allergen profile, and both carry a money-back guarantee. For current pricing and serving details, see the full product specification.

Frequently Asked Questions

How long should I wait between vitamin C and my medication?

It depends on where the interaction happens. Spacing by two to three hours helps when the effect occurs in the gut, as with antacids, but it does nothing for effects that happen in the bloodstream, such as the statin and niacin combination or chemotherapy. For those, the answer is your prescriber rather than your clock.

Does vitamin C affect warfarin or other blood thinners?

Warfarin appears on most consumer interaction lists but not among the NIH's two examples, and the claim rests on a small number of old case reports rather than controlled trials. Because warfarin has a narrow therapeutic range and is monitored by INR testing anyway, the sensible step is to tell your anticoagulation clinic what you take and keep the dose steady rather than starting and stopping.

Can I take vitamin C with levothyroxine?

Yes, and the evidence suggests it may help rather than hinder: a 2014 trial found vitamin C improved levothyroxine absorption in patients with gastritis. The caution is consistency, since changing your vitamin C intake could change how much levothyroxine you absorb, so tell your prescriber before you start or stop.

Should I stop taking vitamin C before a blood test?

Ask the clinic rather than deciding yourself, because it depends on the test. Doses as ordinary as 350 to 1,000 mg a day interfered with reagent strip testing, and vitamin C can produce false negatives on guaiac stool blood tests and urine dipsticks.

Does liposomal vitamin C change the interaction picture?

Possibly, and this has not been studied directly. Liposomal delivery is intended to raise absorption, and in principle a form that achieves higher plasma concentrations could alter an interaction that depends on concentration — but no trial has tested interactions specifically with liposomal forms, so treating it as equivalent to standard vitamin C is the cautious default. Our guide to how much vitamin C to take per day covers the dose ranges involved.

Who should be most careful about vitamin C and medication?

People undergoing cancer treatment, people on levothyroxine or anticoagulants, and people with reduced kidney function or an iron-overload condition such as haemochromatosis. For everyone in those groups the 2,000 mg a day tolerable upper intake level is a sensible ceiling and a physician conversation is worth having.

Conclusion

The short answer to what medications cannot be taken with vitamin C is: fewer than the internet claims, and not always the ones you expect. The NIH names two examples, one entry on the standard list actually improves absorption of the drug it supposedly blocks, and the most consistently documented effect is on lab results rather than on medicines. If you are choosing a vitamin C to fit around a prescription, review the full product specification and bring it to your pharmacist.

Research References

1. Vitamin C pharmacokinetics: implications for oral and intravenous use. Annals of Internal Medicine, Vol. 140, Issue 7 (2004). Established that oral dosing caps plasma vitamin C near 220 micromoles per litre, the ceiling that limits most concentration-dependent interactions.
2. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. New England Journal of Medicine, Vol. 345, Issue 22 (2001). The HATS trial of 160 patients, in which an antioxidant mixture including vitamin C blunted the HDL rise from simvastatin-niacin therapy.
3. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Research, Vol. 68, Issue 19 (2008). Laboratory work showing reduced cytotoxicity of several chemotherapy agents, one side of the unresolved cancer treatment debate.
4. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis. Journal of Clinical Endocrinology & Metabolism, Vol. 99, Issue 6 (2014). Found that vitamin C improved levothyroxine absorption, reversing the direction of the usual warning.
5. Vitamin C supplementation in patients with hypothyroidism requiring high-dose levothyroxine: a proof-of-concept pilot study. Frontiers in Endocrinology, Vol. 16 (2025). Pilot trial of 1 gram of vitamin C daily against placebo, detecting a therapeutic signal mainly in clinical symptoms.
6. Absorption and retention of aluminum from drinking water: effect of citric and ascorbic acids on aluminum tissue levels in rabbits. Fundamental and Applied Toxicology, Vol. 14, Issue 4 (1990). Animal study finding that ascorbate did not raise aluminium in any tissue examined and reduced bone accumulation.
7. Ascorbic acid interference in reagent strip testing. Clinical Chemistry, Vol. 32, Issue 4 (1986). Found that daily doses of 350 to 1,000 mg frequently interfered with all four reagent strip systems tested.
8. Ascorbic acid and ethinyl estradiol in women using a combined oral contraceptive. Contraception (1993) [journal volume not confirmed]. In 37 women, 1 gram of vitamin C daily did not raise ethinyl estradiol levels.
9. Vitamin C — Health Professional Fact Sheet. National Institutes of Health, Office of Dietary Supplements (updated 2025). Gives two examples of medication interactions, the 2,000 mg tolerable upper intake level, and the absorption figures across intake ranges.
10. 510(k) decision summary K211102. United States Food and Drug Administration. Notes that more than 500 mg a day of ascorbic acid can affect continuous glucose sensor readings.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.